Raphas Co. Ltd (214260) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.014x

Based on the latest financial reports, Raphas Co. Ltd (214260) has a cash flow conversion efficiency ratio of -0.014x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-452.25 Million ≈ $-306.48K USD) by net assets (₩32.62 Billion ≈ $22.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Raphas Co. Ltd (214260) defensive interval to measure how many days the company can operate on defensive assets alone.

Raphas Co. Ltd - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Raphas Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Raphas Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Raphas Co. Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Arrow Syndicate Public Company Limited
BK:ARROW
0.052x
T Scientific Co.Ltd
KQ:057680
-0.008x
Tinka Resources Limited
V:TK
-0.006x
IGM Biosciences Inc
NASDAQ:IGMS
-0.503x
Sequans Communications SA
NYSE:SQNS
-0.204x
Equity Metals Corp
V:EQTY
-0.520x
Kafein Yazilim
IS:KFEIN
0.024x
SK Innovation Co Ltd Pref
KO:096775
0.056x

Annual Cash Flow Conversion Efficiency for Raphas Co. Ltd (2017–2024)

The table below shows the annual cash flow conversion efficiency of Raphas Co. Ltd from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see 214260 market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩29.36 Billion
≈ $19.90 Million
₩4.88 Billion
≈ $3.31 Million
0.166x +397.25%
2023-12-31 ₩32.31 Billion
≈ $21.89 Million
₩-1.81 Billion
≈ $-1.23 Million
-0.056x +36.98%
2022-12-31 ₩40.93 Billion
≈ $27.74 Million
₩-3.63 Billion
≈ $-2.46 Million
-0.089x -639.31%
2021-12-31 ₩52.36 Billion
≈ $35.48 Million
₩862.01 Million
≈ $584.17K
0.016x -19.52%
2020-12-31 ₩44.18 Billion
≈ $29.94 Million
₩903.85 Million
≈ $612.53K
0.020x +135.31%
2019-12-31 ₩47.83 Billion
≈ $32.42 Million
₩-2.77 Billion
≈ $-1.88 Million
-0.058x -79.15%
2018-12-31 ₩20.13 Billion
≈ $13.64 Million
₩-651.09 Million
≈ $-441.23K
-0.032x +50.53%
2017-12-31 ₩23.74 Billion
≈ $16.09 Million
₩-1.55 Billion
≈ $-1.05 Million
-0.065x --

About Raphas Co. Ltd

KQ:214260 Korea Biotechnology
Market Cap
$46.44 Million
₩68.53 Billion KRW
Market Cap Rank
#22246 Global
#1384 in Korea
Share Price
₩8150.00
Change (1 day)
+1.88%
52-Week Range
₩6720.00 - ₩17280.00
All Time High
₩75400.00
About

Raphas Co., Ltd. manufactures and sells biodegradable microneedles in Korea. The company offers skin care, medical device, whitening care, and wrinkle care under the Acropass brand; and health food product under the FitKong brand. It also supplies double-layer microneedle manufacturing technology; and provides original development manufacturing, and contract development and manufacturing organiza… Read more